Bio-Techne TECH Estimates

NASDAQ TECH
$72.42 -0.03 (-0.04%)
As of: Sep 4, 2026 · 1:11 PM EDT
Analyst Estimates

BIO-TECHNE Corp Revenue Estimates

Periods 25
Next Period Q4 26
Consensus 306.97 M

Analysts expect BIO-TECHNE Corp to report revenue of 306.97 M for Q4 26, against a range of 289.21 M to 324.74 M. The most recent reported quarter, Q3 26, came in at 311.42 M, a 1.9% beat against the 305.69 M consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 306.10 M289.46 M297.03 M316.18 M316.96 M286.56 M295.88 M311.42 M--------
High Estimate 338.29 M326.28 M300.14 M354.82 M358.60 M306.64 M282.50 M326.10 M324.74 M320.48 M340.80 M366.37 M339.11 M368.80 M370.25 M375.29 M
Low Estimate 308.46 M271.33 M247.70 M320.25 M307.98 M251.18 M262.77 M285.27 M289.21 M278.78 M293.03 M320.57 M280.05 M309.78 M328.30 M331.43 M
Consensus Estimate 323.37 M298.80 M273.92 M337.53 M333.29 M278.91 M272.63 M305.69 M306.97 M299.63 M316.92 M343.47 M309.58 M339.29 M349.27 M353.36 M
Analyst Estimates

BIO-TECHNE Corp Earnings Per Share (EPS) Estimates

Periods 25
Next Period Q4 26
Consensus 0.50

Analysts expect BIO-TECHNE Corp to report earnings per share of 0.50 for Q4 26, against a range of 0.46 to 0.54. The most recent reported quarter, Q3 26, came in at 0.53, a 5.4% miss against the 0.56 consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 0.490.420.420.560.530.420.460.53--------
High Estimate 0.550.430.420.540.560.480.490.590.540.500.490.630.600.530.610.72
Low Estimate 0.490.370.380.440.460.400.410.530.460.440.450.550.560.470.550.60
Consensus Estimate 0.520.400.400.490.510.440.450.560.500.470.470.590.580.500.580.66